You are here:     > Corporate Overview > Glenmark at a glance

Glenmark at a glance

We are a leading research-driven, global and integrated pharmaceutical organisation committed to making a difference in patients’ lives. Since our entry into the pharmaceutical industry in 1977, we have emerged as a leading player in the discovery of novel molecules, both NCEs (New Chemical Entity) and NBEs (New Biological Entity), and differentiated generic formulations.

We have several molecules in various stages of pre-clinical and clinical development and are primarily focussed in the areas of oncology, respiratory and dermatology. We have improved the lives of millions of patients by offering safe and affordable medications for nearly 40 years.

Strategic research and development form the basis of all our offerings and we have more than 13,000 employees from 60 nationalities dedicated to the goal of enriching lives across the globe.

1. Source: Scrip 100 - 2017 Rankings

Glenmark’s business divisions

Glenmark’s manufacturing facility at Goa, India

Our business is primarily structured into Branded and Generic Formulations, Active Pharmaceutical Ingredients (APIs), and Novel Molecular Entities (NME) & Specialty Products.